Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 102751
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.102751
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.102751
Table 1 Clinical baseline characteristics of the normotension group, low systolic blood pressure variability group, and high systolic blood pressure variability group
Variables | Normotension group, n = 213 | Low SBPV group, n = 334 | High SBPV group, n = 334 | P value |
Baseline characteristic | ||||
Age (years) | 58.24 ± 9.32 | 61.83 ± 10.19a | 65.03 ± 10.88a,b | < 0.001 |
Male sex | 90 (42.3) | 164 (49.1) | 193 (57.8)a,b | 0.001 |
Body mass index (kg/m2) | 23.71 ± 3.15 | 24.12 ± 3.13 | 24.73 ± 3.99a | 0.009 |
Smoking | 33 (15.5) | 57 (17.1) | 71 (21.2) | 0.187 |
Dyslipidemia | 94 (44.1) | 135 (40.4) | 163(48.8) | 0.115 |
Systolic pressure (mmHg) | 118 ± 9 | 136 ± 10a | 149 ± 16a,b | < 0.001 |
Diastolic pressure (mmHg) | 73 ± 8 | 78 ± 11a | 85 ± 14a,b | < 0.001 |
Laboratory findings | ||||
Fast glucose (mmol/L) | 6.68 ± 2.87 | 7.66 ± 2.82 | 7.72 ± 3.93a,b | 0.005 |
HbA1c (%) | 7.37 ± 2.36 | 7.42 ± 1.86a | 7.79 ± 1.97a | 0.027 |
Triglyceride (mmol/L) | 1.36 (0.91, 1.82) | 1.46 (0.81, 2.11) | 1.55 (0.68, 2.41)a,b | 0.001 |
Total cholesterol (mmol/L) | 4.41 ± 1.20 | 4.44 ± 1.19 | 4.64 ± 1.26a | 0.004 |
HDL-cholesterol (mmol/L) | 1.25 ± 0.36 | 1.26 ± 0.35 | 1.28 ± 0.38a,b | 0.007 |
LDL-cholesterol (mmol/L) | 2.59 ± 0.85 | 2.69 ± 0.95 | 2.79 ± 0.96a,b | < 0.001 |
Lipid - lowering medication | ||||
Statin | 128 (60.1) | 214 (64.1) | 261 (78.1)a,b | 0.001 |
Hypertension treatment | ||||
ARB/ACEI | - | 128 (38.3) | 82 (24.6)b | < 0.001 |
Beta - blocker | - | 87 (26.1) | 65 (19.5) | 0.064 |
Diuretics | - | 27 (8.1) | 22 (6.6) | 0.830 |
Calcium channel blocker | - | 119 (35.6) | 163 (48.8)b | 0.001 |
Diabetes treatment | ||||
Oral | 77 (36.1) | 142 (42.5) | 183 (54.8)a,b | < 0.001 |
Insulin | 36 (16.9) | 57 (17.1) | 70 (20.1) | 0.192 |
Tube voltage of CT acquisition (kVp) | 0.002 | |||
100 | 139 (65.3) | 183 (54.8) | 152 (45.5) | |
120 | 71 (33.4) | 144 (43.1) | 158 (47.3) | |
140 | 3 (1.4) | 7 (2.1) | 24 (7.2) |
- Citation: Jiang CP, Liu YK, Cheng PP, Dong Y, Wang X, Wu FY, Xia YX, Wang PY, Xu XY. Effect of systolic blood pressure status on coronary inflammation and high-risk plaque characteristics. World J Diabetes 2025; 16(4): 102751
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/102751.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.102751